Avoid common mistakes on your manuscript.
Correction to: Mol Imaging Biol
The article “Pre-therapy Somatostatin Receptor-Based Heterogeneity Predicts Overall Survival in Pancreatic Neuroendocrine Tumor Patients Undergoing Peptide Receptor Radionuclide Therapy,” written by Rudolf A. Werner, Harun Ilhan, Sebastian Lehner, László Papp, Norbert Zsótér, Imke Schatka, Dirk O. Muegge, Mehrbod S. Javadi, Takahiro Higuchi, Andreas K. Buck, Peter Bartenstein, Frank Bengel, Markus Essler, Constantin Lapa, and Ralph A. Bundschuh was originally published electronically on the publisher’s internet portal (currently SpringerLink) on July 16, 2018 without open access.
With the author(s)’ decision to opt for Open Choice the copyright of the article changed on July 25, 2018 to © The Author(s) 2018 and the article is forthwith distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits use, duplication, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license and indicate if changes were made.
Author information
Authors and Affiliations
Corresponding author
Additional information
The online version of the original article can be found at https://doi.org/10.1007/s11307-018-1252-5
Rights and permissions
About this article
Cite this article
Werner, R.A., Ilhan, H., Lehner, S. et al. Correction to: Pre-therapy Somatostatin Receptor-Based Heterogeneity Predicts Overall Survival in Pancreatic Neuroendocrine Tumor Patients Undergoing Peptide Receptor Radionuclide Therapy. Mol Imaging Biol 20, 1068 (2018). https://doi.org/10.1007/s11307-018-1261-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11307-018-1261-4